JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 34 No. 2 255-259
© 1993 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maublant, J. C.
Right arrow Articles by Veyre, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maublant, J. C.
Right arrow Articles by Veyre, A.

Uptake of Technetium-99m-Teboroxime in Cultured Myocardial Cells: Comparison with Thallium-201 and Technetium-99m-Sestamibi

Jean C. Maublant, Nicole Moins, Pierre Gachon, Monique Renoux, Zheng Zhang and Annie Veyre

Division of Nuclear Medicine, Centre Jean Perrin and INSERM U195 and U71, Faculty of Medicine, Université d'Auvergne, 63011 Clermont-Ferrand, France

Correspondence: For correspondence and reprints contact: Jean C. Maublant, MD, PhD, Division of Nuclear Medicine, Centre Jean Perrin, 63011 Clermont-Ferrand, France.

ABSTRACT

The effects of metabolic inhibition on the uptake of 99mTc-teboroxime were assessed in cultured myocardial cells and compared with 201Tl and 99mTc-sestamibi. Metabolic impairment was induced by cyanide (CN), a blocker of the mitochondrial respiratory chain, iodoacetate (IAA), an inhibitor of the glycolytic pathway, and ouabain, an inhibitor of Na+-K+ sarcolemmal ATPase. Cellular viability was appreciated by the trypan blue exclusion method. The effects of low temperature and of cellular death resulting from osmotic lysis were also assessed. Net cellular uptake of the radiotracers and the amount of proteins in the culture dishes were measured. All experiments were performed in parallel with control conditions and the results were expressed relatively to the control values. Teboroxime uptake was clearly decreased at low temperature (29.6% ± 2.2% at 0°C, p < 0.001), while metabolic inhibition or osmotic lysis had no definite effect. The uptake of 201Tl and sestamibi was severely diminished in the presence of a mixture of 5 mM CN and 0.1 mM IAA, but 201Tl was less resistant than sestamibi (13.7% ± 0.3% and 73.5% ± 3.3%, respectively, after 1 hr of preincubation, p < 0.001 for both). Uptake of both tracers was very low in the presence of dead cells (12.1% ± 1.3% for 201Tl and 4.1% ± 0.2% for sestamibi, p < 0.001 for both). Ouabain had a detrimental effect only on 201Tl uptake at doses higher than 100 µM. Of these three currently available coronary blood flow imaging agents, teboroxime shows the lowest sensitivity to metabolic impairment.




This article has been cited by other articles:


Home page
CirculationHome page
G. Vanzetto, D. K. Glover, M. Ruiz, D. A. Calnon, R. Pasqualini, D. D. Watson, and G. A. Beller
99mTc-N-NOET Myocardial Uptake Reflects Myocardial Blood Flow and Not Viability in Dogs With Reperfused Acute Myocardial Infarction
Circulation, May 23, 2000; 101(20): 2424 - 2430.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. Riou, C. Ghezzi, O. Mouton, J.-P. Mathieu, R. Pasqualini, M. Comet, and D. Fagret
Cellular Uptake Mechanisms of 99mTcN-NOET in Cardiomyocytes From Newborn Rats : Calcium Channel Interaction
Circulation, December 8, 1998; 98(23): 2591 - 2597.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Cinca, A. Garcia-Burillo, A. Carreno, J. Castell, M. Warren, J. Candell-Riera, A. Domingo, and J Soler-Soler
Differential uptake of myocardial perfusion radiotracers in normal, infarcted, and acutely ischemic peri-infarction myocardium
Cardiovasc Res, April 1, 1998; 38(1): 91 - 97.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1993 by the Society of Nuclear Medicine.